---

Day Care Surgery - PG Seminar: Short Answer / Viva Questions

---

SECTION 1: Definition, Background & Concepts

• Bailey & Love 28e, p. 320

1. Improved anaesthesia techniques (shorter-acting agents, regional blocks)
2. Development of minimally invasive (laparoscopic/endoscopic) procedures
3. Healthcare policy changes - particularly funding reforms and financial incentives for hospitals to shift elective procedures to outpatient settings Outpatient procedures grew from 19% to 60% of all US surgical volume between 1981 and 2011.

• Schwartz's 11e

• Hospital outpatient departments (HOPDs)
• Freestanding ambulatory surgery centres (ASCs)
• Physician's office-based surgical suites
• Schwartz's 11e

• Patient recovers in the comfort of home
• Less disruption to domestic/family life
• Reduced risk of hospital-acquired infection
• Greater patient satisfaction scores
• Frees inpatient beds for those who genuinely need them
• Lower cost than inpatient admission
• Activity can continue even during inpatient bed pressures
• Bailey & Love 28e, p. 320

---

SECTION 2: Patient Selection Criteria

• Current Surgical Therapy 14e, p. 1487; Bailey & Love 28e, p. 321

• ASA 4 or 5 - absolute exclusion
• Unstable ASA 3 or any poorly controlled comorbidity Stable ASA 3 patients may be considered case-by-case with optimisation.
• Bailey & Love 28e, p. 321

• Recent (<3 months) new-onset, unstable, or severe angina
• Recent MI or coronary stenting
• New-onset or decompensated heart failure
• Severe valve dysfunction
• High-grade AV block
• Cerebrovascular disease (TIA/CVA)
• Acute respiratory disease
• End-stage renal disease not on regular dialysis
• Current Surgical Therapy 14e, p. 1487

1. Low risk of significant immediate postoperative complications (catastrophic bleeding, airway compromise)
2. Patient able to eat, drink, or take oral nutrition postoperatively
3. Postoperative pain manageable with oral analgesia +/- LA infiltration or peripheral nerve block
4. Patient able to mobilise postoperatively (with or without aid)

• Bailey & Love 28e, p. 321

• Well-controlled diabetes (HbA1c <69 mmol/mol / ~8.5%) - can be safely managed as a day case
• Poorly controlled diabetes - surgery should be delayed until control is optimised
• These patients have increased risk of cardiovascular complications and poor wound healing
• Schedule first on the operating list to minimise fasting duration
• Bailey & Love 28e, p. 322

• Poor functional capacity
• SpO2 <94% on room air Suitable obese patients should receive short-acting anaesthetic, avoid long-acting opiates, and allow extra time for anaesthetic recovery.
• Bailey & Love 28e, p. 322

• Bailey & Love 28e, p. 321

• A responsible adult available to escort the patient home
• A responsible adult to stay with the patient for 24 hours postoperatively
• Access to a phone (for emergencies)
• Appropriate home circumstances
• Ability to understand and follow written postoperative instructions
• Bailey & Love 28e, p. 324

---

SECTION 3: Common Day Case Procedures

• Bailey & Love 28e, p. 321

• Bailey & Love 28e, p. 321

---

SECTION 4: Anaesthesia in Day Surgery

• Meticulous attention to pain relief and prevention of PONV
• Multimodal analgesia approach with premedication
• Short-acting general anaesthetic agents (e.g., propofol/desflurane/sevoflurane)
• Day case spinals or regional anaesthesia techniques
• Avoidance of long-acting opioids (e.g., IV morphine) - can delay recovery through sedation or nausea
• Bailey & Love 28e, p. 323

• Minimal number of drug combinations (additive/synergistic effects)
• Prefer short-acting agents at lowest effective doses
• Superiority of TIVA vs. inhalational anaesthesia remains unclear
• Opioid-free anaesthesia is controversial - adjuncts (ketamine, dexmedetomidine, lidocaine, Mg infusion) may themselves impair recovery
• Current Surgical Therapy 14e, p. 1487

• Lung-protective ventilation: tidal volume 6-8 mL/kg ideal body weight
• PEEP: 5-10 cm H2O
• ETCO2 target: ~40 mmHg (rather than traditional 30-35 mmHg) - improves tissue and organ perfusion
• Current Surgical Therapy 14e

• Baseline: 3-5 mL/kg/h balanced crystalloid
• Blood loss replaced with balanced crystalloid at 1:1.5 ratio
• Goal-directed fluid therapy (guided by cardiac output monitoring) for high-risk patients with expected blood loss >1000 mL
• Current Surgical Therapy 14e

• Scopolamine transdermal patch (1-3 h preop)
• Aprepitant 40 mg PO (1-3 h preop)
• Dexamethasone 8-10 mg IV at induction (also analgesic/anti-inflammatory)
• Ondansetron 4 mg IV or palonosetron 0.75 mg IV (end of surgery)
• Droperidol 0.625-1.25 mg IV (end of surgery)

• Current Surgical Therapy 14e, p. 1487

---

SECTION 5: List Planning & Perioperative Pathway

• Procedures with longer recovery times (tonsillectomy, knee/hip replacement, complex lap. cholecystectomy) should be placed early on the list
• Exceptions: insulin-dependent diabetics and patients with learning difficulties should be first on the list (to minimise fasting time and waiting anxiety)
• Patients should be encouraged to walk to theatre
• Drains should be generally avoided; if used, clear removal plans must be documented at the time of surgery
• Bailey & Love 28e, p. 323

• Can surgery be delayed until the medical condition is optimised, and then planned as a day case?
• Can social factors be addressed to make the patient a suitable day case? Anaesthetist should review notes and discuss suitability with the day surgery lead. Nurse-led assessment with anaesthetic review is the standard model.
• Bailey & Love 28e, p. 323

---

SECTION 6: Discharge Criteria

1. Vital signs stable for at least 1 hour
2. Correct orientation to time, place, and person (where applicable)
3. Adequate pain control with oral analgesia supplied
4. Patient understands how to use the supplied analgesia
5. Ability to dress and walk where appropriate
6. Minimal nausea, vomiting, or dizziness
7. Has taken oral fluids
8. Minimal bleeding or wound drainage
9. Has passed urine (where appropriate)
10. Has a responsible adult to take them home
11. Written and verbal postoperative instructions given
12. Knows when to return for follow-up (if applicable)
13. Emergency contact number provided

• Bailey & Love 28e, p. 324

1. Vital signs
2. Ambulation and mental status
3. Pain
4. Nausea/vomiting
5. Surgical bleeding
6. Fluid intake/output

• Miller's Anesthesia 10e

• Miller's Anesthesia 10e

• Bailey & Love 28e, p. 324

• Bailey & Love 28e, p. 324

---

SECTION 7: Complications & Unplanned Admission

• Miller's Anesthesia 10e

• Orthopaedic and urologic procedures (highest pain risk)
• Higher BMI
• Longer duration of anaesthesia
• Female sex, non-smoker, history of PONV/motion sickness (classic Apfel risk factors for PONV)
• Miller's Anesthesia 10e

• Uncontrolled pain
• Intractable PONV
• Intraoperative haemorrhage or unexpected findings requiring extended surgery
• Postoperative haemorrhage (especially tonsillectomy)
• Urinary retention
• Adverse anaesthetic events (prolonged sedation, laryngospasm)
• Cardiovascular instability
• Current Surgical Therapy 14e; Bailey & Love 28e

---

SECTION 8: High-Yield Viva Rapid-Fire Questions

---

---

Hydrocephalus - Comprehensive Topic Notes (PG Level)

---

1. Definition

Note: "Hydrocephalus" literally means "water on the brain" and is a nonspecific term - it must be distinguished from ventriculomegaly due to cerebral atrophy ("hydrocephalus ex vacuo"), which does NOT benefit from intervention.

---

2. CSF Physiology (essential foundation)

---

3. Classification

3a. Obstructive (Non-Communicating) Hydrocephalus

• Obstruction lies within the ventricular system - CSF cannot exit the ventricles
• Ventricles proximal to the obstruction dilate; ventricles distal remain normal
• LP carries a risk of herniation (coning) - contraindicated until obstruction excluded
• Causes:
  • Lesions within the ventricle (colloid cyst of 3rd ventricle, ependymoma, cysticercosis)
  • Lesions in the ventricular wall
  • Distant mass with pressure effect
  • Aqueductal stenosis (most common cause in children)
  • Posterior fossa tumours (cerebellum/brainstem)
  • Chiari malformations

3b. Communicating (Extraventricular Obstructive) Hydrocephalus

• Obstruction at or beyond the subarachnoid space - ventricles communicate with each other but drainage is impaired
• Entire ventricular system dilates
• LP is safe and diagnostically useful (opening pressure, CSF analysis, therapeutic drainage)
• Causes:
  • Post-haemorrhagic (SAH, IVH)
  • Post-infective (meningitis - TB, bacterial, fungal)
  • Raised CSF protein
  • Leptomeningeal carcinomatosis

3c. Overproduction (rare)

• Choroid plexus papilloma / carcinoma

---

4. Aetiology by Age Group

Neonates / Infants (fontanelles open, <2 years)

• Intraventricular haemorrhage (IVH) - especially in premature infants <1500 g; 25% develop progressive ventricular enlargement; 5% require shunting
• Post-infective - in utero infection causing aqueductal scarring/closure
• Aqueductal stenosis/gliosis (congenital or acquired)
• Chiari II malformation (associated with myelomeningocele)
• Dandy-Walker malformation - cystic expansion of 4th ventricle, absent/hypoplastic vermis
• Congenital midline tumours
• Vein of Galen malformation

Older Children (fontanelles closed, >2-3 years)

• Posterior fossa tumours (most common) - medulloblastoma, ependymoma, astrocytoma
• Aqueductal stenosis
• Meningitis

Adults

• Colloid cyst of the third ventricle - ball-valve effect, intermittent/sudden obstruction, risk of sudden death
• Cerebellar haemorrhage or infarction - compresses brainstem, blocks aqueduct and 4th ventricle outflow
• SAH, bacterial/TB/fungal meningitis
• Tumours of basal cisterns
• Normal pressure hydrocephalus (NPH) - idiopathic, or following SAH, head injury, meningitis

---

5. Clinical Features

In Infants (sutures open)

In Older Children (sutures closed)

• Early morning headache, nausea, vomiting (ICP highest on waking)
• Papilloedema
• Diplopia (VI nerve palsy - false localising)
• Visual blurring, ataxia
• Altered conscious level
• Wide-based ataxic gait (stretching of frontal-leg white-matter tracts)
• Deep tendon reflexes increased as spasticity develops
• Long-standing: endocrine dysfunction (short stature, menstrual irregularities, diabetes insipidus) from 3rd ventricle involvement

In Adults (acute)

• Headache, papilloedema, diplopia
• Mental status changes
• Sudden death (severe cases)
• Akinetic mutism (pressure on structures around 3rd ventricle - rare)
• Temporal lobe seizures
• CSF rhinorrhoea
• Endocrine dysfunction (amenorrhoea, polydipsia, polyuria, obesity) - 3rd ventricle dysfunction

---

6. Normal Pressure Hydrocephalus (NPH)

Classic Triad (Hakim-Adams Triad)

1. Gait disturbance - earliest and most prominent feature
2. Cognitive decline (frontal-type: apathy, dullness, impaired memory)
3. Urinary incontinence (urgency → incontinence → "frontal lobe incontinence")

Gait in NPH

• Unsteady, slow, short steps - difficulty on stairs/curbs
• May superficially resemble Parkinsonism (short steps, stooped posture) but:
  • No shuffling or festination
  • No rigidity, no resting tremor
  • No bradykinesia
  • No Babinski signs
• Unexplained falls (often backward)

Aetiology

• Idiopathic (most common)
• Secondary: SAH, head injury, meningitis, tumour

Pathophysiology

• CSF pressure at LP is normal on random measurement
• But: reduced brain compliance causes transient ICP spikes that drive ventricular enlargement
• Ventricular enlargement began at a time of higher pressure; compensatory mechanisms later normalise the measured pressure

Prevalence

• ~0.2% in ages 70-79; ~5.9% in those >80

Diagnosis

• Clinical triad + ventriculomegaly on imaging
• Lumbar infusion/drainage studies - demonstrate altered compliance and/or clinical improvement with CSF removal (30-50 mL tap test)
• Must be distinguished from ventriculomegaly from cortical atrophy

Treatment

• Ventriculoperitoneal (VP) shunt - treatment of choice
• Gait responds best; cognitive and urinary symptoms respond less predictably

---

7. Investigations

Imaging

• First-line for emergency assessment
• Shows ventricular enlargement, periventricular lucency (transependymal oedema)
• Signs of raised ICP (sulcal effacement, loss of basal cisterns)
• Classically in chronic hydrocephalus: erosion of dorsum sellae, copper-beaten skull (less reliable)

• Superior to CT for posterior fossa, aqueduct, brainstem, Chiari malformations
• Identifies site of obstruction (sagittal T2 best for aqueduct)
• Periventricular interstitial oedema (transependymal flow) on T2/FLAIR
• Identifies underlying cause (tumour, haemorrhage, infection)
• ETV patency: large T2 hypointense flow voids through the ventriculostomy

• Dilatation of temporal horns disproportionate to lateral ventricular dilatation
• Enlargement of anterior/posterior recesses of 3rd ventricle
• Inferior convexity of the floor of the 3rd ventricle
• Transependymal (periventricular) oedema
• Small/obliterated sulci, fissures, and basal cisterns

• Lateral + 3rd ventricles dilated; 4th ventricle normal
• Focal narrowing at superior colliculi or intercollicular sulcus on sagittal T2
• Aqueduct dilated proximal to stenosis

• Ventricular dilatation (compare with baseline)
• Fluid tracking along shunt tubing
• Plain shunt series (skull to abdomen): assess tubing continuity, kinks, disconnection

CSF Analysis (Lumbar Puncture)

• Only safe in communicating hydrocephalus (LP contraindicated in obstructive/non-communicating hydrocephalus - risk of tonsillar herniation)
• Derives opening pressure
• CSF contents: protein, cells, glucose, culture (TB, bacterial, fungal causes)
• Therapeutic drainage (10-30 mL) can provide temporary relief

---

8. Treatment

Emergency / Acute

• External ventricular drain (EVD) - immediate CSF diversion
• Management of acute raised ICP (see ICP chapter)

Medical (temporary / adjunctive)

• Acetazolamide (carbonic anhydrase inhibitor) + furosemide - reduce CSF production rate
• Used for slowly progressive hydrocephalus or as a bridge to surgery

Surgical

A. Ventriculoperitoneal (VP) Shunt - the mainstay of surgical treatment

• Most commonly used CSF diversion procedure
• Catheter from lateral ventricle → one-way pressure-sensitive valve → peritoneal cavity
• Programmable valves allow external adjustment of drainage pressure

B. Ventriculoatrial (VA) Shunt

• CSF drained into the right atrium
• Used when peritoneal cavity not suitable
• Higher risk of cardiac complications (arrhythmia, endocarditis)

C. Endoscopic Third Ventriculostomy (ETV)

• A surgical defect (fenestration) is made in the floor of the third ventricle, allowing CSF to drain into the suprasellar cistern, bypassing the obstruction
• Best suited for non-communicating hydrocephalus with aqueductal obstruction
• Avoids the long-term complications of an indwelling shunt
• ETV patency confirmed on MRI by T2 hypointense flow voids through the fenestration
• Less effective in infants <6 months and post-infective hydrocephalus

D. Surgical removal of obstructing lesion

• Tumours (colloid cyst, posterior fossa tumours) - definitive treatment restores CSF flow

---

9. Special Scenarios

Colloid Cyst of the Third Ventricle

• Benign mucin-filled cyst at the foramen of Monro
• Acts as a ball valve - intermittently blocks CSF flow
• Presents with positional headaches, sudden loss of consciousness, or sudden death
• Treatment: surgical resection (endoscopic or open)

Dandy-Walker Malformation

• Cystic dilation of the 4th ventricle, aplasia/hypoplasia of the cerebellar vermis, enlarged posterior fossa
• Associated with hydrocephalus in ~80%

Chiari II Malformation

• Associated with myelomeningocele
• Posterior fossa structures herniate through foramen magnum
• Can cause hydrocephalus by obstructing 4th ventricle outlets within the spinal canal
• In shunted patients: enlarged or normal-sized 4th ventricle suggests shunt malfunction or isolated 4th ventricle
• Occipital headaches at night = suspect shunt malfunction + risk of brainstem compression

IVH in Premature Infants

• Germinal matrix haemorrhage - risk highest in <1500 g infants
• 25% develop progressive ventricular enlargement; 5% require VP shunting
• Ventricular size followed by bedside cranial ultrasound through the open fontanelle

---

10. Key Facts Summary Table

---

---

Brain Stem Death - Comprehensive Topic Notes (PG Level)

---

1. Historical Background

• 1959 - Mollaret and Goulon first described "coma dépassé" (irreversible coma), marking the conceptual birth of brain death
• 1968 - The Harvard Ad Hoc Committee published the first widely accepted criteria for brain death, then called "irreversible coma"
• 1976 - The Conference of Medical Royal Colleges and Faculties of the United Kingdom issued guidelines on brain stem death (regularly updated; used throughout NHS)
• USA - The Uniform Determination of Death Act (UDDA) established that brain death = death of the person
• India - The Transplantation of Human Organs and Tissues Act (THOTA), 1994 (amended 2011) governs brain death certification and organ donation

"The concept of brain death is not simply a convenience invented to satisfy the demands of transplant surgeons." - Dikshit

---

2. Concepts of Death

Key distinction: BSD patients are irrefutably dead. Switching off the ventilator "does not kill the patient but discontinues ventilating a corpse." PVS patients raise the moral dilemma of "allowing someone to die."

---

3. Why Brain Stem Death = Death

• Controls respiration (medullary respiratory centres)
• Controls circulation (cardiovascular centres)
• Maintains consciousness (reticular activating system, ARAS)
• Mediates all cranial nerve reflexes

"All death is brain death. Even if all other organs were artificial, the individual would still be alive. Conversely, when the brain is dead, sustaining other organs is simply preserving a dead body." - Plum & Posner

---

4. Most Common Causes of Brain Death

1. Traumatic brain injury (most common overall)
2. Aneurysmal subarachnoid haemorrhage
3. Intracerebral haemorrhage
4. Ischaemic stroke with cerebral oedema and herniation
5. Hypoxic-ischaemic encephalopathy (cardiac arrest)
6. Fulminant hepatic necrosis with cerebral oedema and raised ICP

---

5. Prerequisites / Preconditions Before Testing

5a. The Three Preconditions (UK / Dikshit)

1. The patient must be in deep coma
2. The patient must be maintained on a mechanical ventilator
3. The cause of the coma must be established and irreversible (known structural or metabolic cause)

5b. The Three Exclusions - Conditions That Must Be Ruled Out

1. Drug effects - therapeutic drugs (sedatives, anaesthetics, neuromuscular blockers) or overdose (alcohol, opioids, benzodiazepines)
2. Hypothermia - core body temperature must be above 35°C (UK) / above 36.5°C (AAN/US). Must warm patient before testing
3. Severe metabolic or endocrine disturbances - e.g. severe hypoglycaemia, hyperglycaemic coma, electrolyte disturbances, uraemia, hepatic encephalopathy

Note: Diabetes insipidus is a common complication of severe brain injury. It may appear hours or days after other signs of brain death and is not a diagnostic criterion.

5c. Additional Prerequisites (AAN guidelines, Plum & Posner)

• Systolic BP must be maintained >90 mmHg (dopamine infusion if needed)
• Pre-test arterial blood gases: PaO2 >200 mmHg, PaCO2 ≥40 mmHg
• Euvolemia or positive fluid balance for at least 6 hours before testing
• Cervical spine injury excluded before oculocephalic testing (if trauma suspected)

---

6. Who Performs the Tests

---

7. The Brainstem Death Tests

Key notes on Pupils

• Harvard criteria (1968) required dilated AND fixed pupils
• Current standard: mid-position fixed pupils are more reliable - initially after brain death, agonal catecholamine release dilates pupils, but as catecholamines clear, pupils return to mid-position
• Exclude prior use of mydriatics (atropine), miotic drugs
• Neuromuscular blockers do NOT affect pupil size (nicotinic receptors not present in iris)

---

8. The Apnoea Test - in Detail

Rationale

• PaCO2 must rise high enough to maximally stimulate the medullary respiratory centres before declaring them non-functional
• In deep coma, the CO2 threshold for respiratory stimulation may be elevated (up to 50-55 mmHg)
• Rate of rise of PaCO2 during apnoea: ~3 mmHg/min (UK: 2-3 mmHg/min; Harrison's: 2-3 mmHg/min)

Procedure (Apnoeic Oxygenation)

1. Pre-oxygenate with 100% oxygen for 10-20 minutes
2. Pre-test ABG: confirm PaO2 >200 mmHg, PaCO2 ≥40 mmHg
3. Disconnect the ventilator
4. Deliver O2 via tracheal catheter at 6 L/min (maintains oxygenation via apnoeic diffusion for ≥1 hour)
5. Observe for any chest/abdominal respiratory movements for 8-10 minutes
6. At 8 minutes: draw ABG
7. Reconnect ventilator

Interpretation

When to stop early

• Cardiovascular instability / hypotension (SBP <90 mmHg) during test
• Severe hypoxia (SpO2 falls critically)
• Arrhythmia

Special situation: ECMO patients

• Traditional apnoea testing cannot be performed on ECMO - ancillary testing required

---

9. Spinal Reflex Activity - a Critical Pitfall

• Deep tendon reflexes may be present
• Plantar responses: flexor, absent, or toe undulations (NOT Babinski - extensor plantar NOT expected in brain death)
• "Lazarus sign" - arms rise and cross over the chest, or body slowly rises to a sitting position - spinally mediated, not a sign of brain function
• Stepping movements
• Body movements synchronous with ventilator

These spinally mediated movements are generated by the spinal cord below the level of the brainstem and do not represent residual brain function.

---

10. Interval Between the Two Examinations

• For anoxic brain injury (cardiac arrest, diffuse insult): minimum 24-hour observation before final diagnosis
• For identified structural injury: shorter evaluation periods acceptable
• For cases with possible drug exposure: 6-hour period of observation (AAN)

---

11. Confirmatory (Ancillary) Tests

• Clinical examination is incomplete (facial trauma, perforated tympanic membrane precluding caloric testing)
• Chronic hypercapnia complicates apnoea testing
• ECMO patients

Note: A normal EEG does not exclude brain death in primary brainstem lesions (brainstem may be dead while cortex temporarily shows electrical activity).

---

12. Certification of Death

• Once both doctors have performed the tests twice and all are negative → patient is pronounced dead
• A death certificate is issued at this point
• The time of death is recorded as the time the first set of tests confirmed brainstem death (not the time the ventilator is switched off)
• After certification, a decision regarding organ donation may be raised and consent obtained from the family

---

13. Legal Framework

United Kingdom

• UK Human Tissue Act 1961: If a person in writing or orally (in presence of 2+ witnesses) during life requested organ donation, organs may be used after death
• Brain stem death guidelines issued by Conference of Medical Royal Colleges (1976, updated regularly)

India - THOTA 1994 (amended 2011)

• Human organ: Heart, kidneys, liver, lungs, pancreas + other government-specified organs
• Tissue: Cornea, bone, skin, blood vessels
• Near relative: Spouse, parents, siblings, children, grandparents, grandchildren
• Brain stem death: Irreversible loss of brain function while maintaining cardiac function (for deceased donation)
• Registered Medical Practitioner (RMP): Doctor recognised to certify brain death

1. Treating physician (in charge of the patient)
2. Neurologist or neurosurgeon
3. Intensivist or anaesthetist
4. Hospital medical administrator (or nominee)

• Section 3: Prohibition of organ removal without authority
• Section 4: Living donor transplantation conditions (near relatives without committee; non-relatives need authorisation committee)
• Section 9: Prohibition of buying/selling human organs - up to 10 years imprisonment + fine up to ₹1 crore
• Section 13: Deceased donation requires lifetime consent OR next-of-kin consent
• Section 15: NOTTO/SOTTO for fair organ allocation
• "Required request" policy - hospitals must ask about organ donation in brain death cases

USA

• Uniform Determination of Death Act (UDDA): Brain death = legal death of the person
• AAN guidelines (reviewed 2010) govern clinical diagnosis

---

14. Brain Death and Organ Donation

• Most transplanted organs in the US/UK come from Donation after Brain Death (DBD) donors
• Donation after Circulatory Death (DCD): organs retrieved after planned withdrawal of life support and cardiac arrest - obligatory warm ischaemia period
• Brain-dead donors have significant physiological alterations that must be actively managed:
  • Haemodynamic instability (loss of sympathetic tone, diabetes insipidus)
  • Endocrine changes (DI, hypothyroidism, adrenal failure)
  • Neurogenic pulmonary oedema
  • Coagulopathy
• Goal-directed donor management improves number of transplantable organs per donor
• Organ viability after brain death (approximate cold ischaemia tolerance):
  • Cornea: viable up to 24 hours
  • Heart: most sensitive - very short ischaemia tolerance
  • Kidney: most tolerant - can be preserved for hours

---

15. Brain Death vs. Persistent Vegetative State - Key Comparisons

---

16. Summary Table - Brainstem Reflexes Tested

---

17. Quick-Reference Key Facts

---